Silvercrest Asset Management Group LLC Has $20.81 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Silvercrest Asset Management Group LLC increased its position in Encompass Health Co. (NYSE:EHC) by 1.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 251,990 shares of the company’s stock after purchasing an additional 4,258 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in Encompass Health were worth $20,809,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Legacy Wealth Asset Management LLC lifted its holdings in shares of Encompass Health by 1.5% during the first quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock worth $712,000 after purchasing an additional 130 shares during the period. Smith Group Asset Management LLC raised its holdings in Encompass Health by 1.2% during the 1st quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company’s stock worth $997,000 after purchasing an additional 140 shares during the last quarter. Benjamin Edwards Inc. increased its position in shares of Encompass Health by 3.8% during the fourth quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock worth $259,000 after buying an additional 142 shares during the period. Horrell Capital Management Inc. raised its stake in Encompass Health by 0.5% during the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after buying an additional 147 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in Encompass Health by 31.9% in the first quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock worth $51,000 after purchasing an additional 149 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Performance

EHC traded up $0.46 during midday trading on Tuesday, reaching $91.96. The company had a trading volume of 710,463 shares, compared to its average volume of 632,654. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $92.69. The business has a 50-day moving average price of $85.70 and a two-hundred day moving average price of $80.46. The stock has a market cap of $9.26 billion, a PE ratio of 24.80, a P/E/G ratio of 1.43 and a beta of 0.89. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.37 and a current ratio of 1.37.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.74%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, October 1st. Encompass Health’s dividend payout ratio is 16.22%.

Insiders Place Their Bets

In other Encompass Health news, insider Elissa Joy Charbonneau sold 10,000 shares of the company’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $85.02, for a total transaction of $850,200.00. Following the sale, the insider now directly owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP John Patrick Darby sold 14,543 shares of Encompass Health stock in a transaction on Monday, May 6th. The stock was sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the transaction, the executive vice president now directly owns 84,773 shares in the company, valued at $7,115,845.62. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Elissa Joy Charbonneau sold 10,000 shares of the company’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $85.02, for a total value of $850,200.00. Following the sale, the insider now owns 18,594 shares in the company, valued at $1,580,861.88. The disclosure for this sale can be found here. Company insiders own 2.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Stephens restated an “overweight” rating and issued a $94.00 price target on shares of Encompass Health in a report on Wednesday, June 5th. Truist Financial boosted their price target on shares of Encompass Health from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, July 15th. Royal Bank of Canada upped their target price on shares of Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, May 22nd. Mizuho lifted their price target on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Finally, Leerink Partnrs upgraded Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average price target of $96.50.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.